Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Oliceridine for postoperative nausea and vomiting after bimaxillary orthognathic surgery
ChiCTR2500096345Phase 4Not yet recruiting
- Sponsor
- Peking University School and Hospital of Stomatology
- Start
- Jan 2025
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised, double-blind trial of oliceridine in postoperative nausea and vomiting (PONV) and postoperative pain (2 arms), sponsored by Peking University School and Hospital of Stomatology. Primary endpoints: Postoperative nausea and Postoperative vomiting. Planned start Jan 2025; status: not yet recruiting.
02
Drugs
oliceridine
03
Conditions
postoperative nausea and vomiting (PONV)postoperative pain
Beyond the preview
Go deeper on ChiCTR2500096345.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR2500096345.